Skip to main content
Premium Trial:

Request an Annual Quote

Perlegen Pockets $1.7M in NIH Funding; Cash Will Pay for Arthritis, Autism, and Cancer Research

NEW YORK, Dec. 28 (GenomeWeb News) - Perlegen Sciences has won approximately $1.7 million through four recent grants from the US National Institutes of Health, according to the NIH.


The four new grants, which the NIH said are effective as of Dec. 26, but that Perlegen had not previously disclosed, include:

  • $221,819 for studying the genetic association of rheumatoid arthritis;
  • $250,000 for studying the genetic association of autism;
  • $473,243 to study evolutionary conserved sequences in the human genome; and
  • $419,580 to perform a comprehensive mutational analysis of the "cancer genome."
The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.